I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell of lymphatic vessel | 8 studies | 22% ± 5% | |
| smooth muscle cell | 8 studies | 23% ± 7% | |
| classical monocyte | 6 studies | 24% ± 9% | |
| myofibroblast cell | 5 studies | 30% ± 8% | |
| pericyte | 5 studies | 19% ± 4% | |
| natural killer cell | 5 studies | 26% ± 11% | |
| fibroblast | 5 studies | 20% ± 5% | |
| mast cell | 5 studies | 24% ± 7% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 31% ± 13% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 25% ± 10% | |
| connective tissue cell | 3 studies | 27% ± 9% | |
| endothelial cell | 3 studies | 25% ± 5% | |
| dendritic cell | 3 studies | 21% ± 5% |
